Medication adherence to antiretroviral therapy among patients visiting antiretroviral therapy center at Tribhuvan university teaching hospital, Kathmandu, Nepal

Kathmandu University Medical Journal

Volumn 11, Issue 41, 2013, Pages 50-53

  Sharma, S ^a   Khadga, P ^a   Dhungana, G P ^b   Chitrakar, U ^a  

^a TRIBHUVAN UNIVERSITY TEACHING HOSPITAL   (Nepal)

^b TRIBHUVAN UNIVERSITY   (Nepal)

Author keywords

Adherence; HIV AIDS; Kathmandu

Indexed keywords

ANTIRETROVIRUS AGENT;

ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; ATTITUDE TO HEALTH; CD4 LYMPHOCYTE COUNT; CHILD; ECONOMIC ASPECT; EXTENDED FAMILY; FEMALE; FORGETFULNESS; HEALTH CENTER; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MEDICATION COMPLIANCE; MEMORY; NEPAL; PATIENT COMPLIANCE; RELIGION; SCHOOL CHILD; SMOKING HABIT;

EID: 84879268613     PISSN: 18122027     EISSN: 18122078     Source Type: Journal    
DOI: 10.3126/kumj.v11i1.11027     Document Type: Article

References (17)

1. Suvedi BK. Transition of HIV epidemic in Nepal. Kathmandu Univ Med J 2006 Jan-Mar;4(1):115-118.
2. National Center of AIDS and STI control (NCASC). Cumulative HIV/ AIDS situation in Nepal (Fact sheet). NCASC, Teku, Kathmandu.
3. RS Braithwaite, Bryant KJ. Influence of alcohol on adherence to and toxicity of antiretroviral therapy and survival. Alcohol Research and Health 2020, 33(3):280-287.
4. Castro A. Adherence to antiretroviral Therapy: Merging the clinical and social course of AIDS. PLoS Med 2005;2(12):338.
5. Hogan D, Salomon J et al; Prevention and treatment of HIV/AIDS in resource limioted settings. Bulletin of WHO.2005 Feb;83(2).
6. Stone VE. Strategies for optimizing adherence to highly active antiretroviral therapy. Lessons from research and clinical practice. Clinical Infectious diseases 2001;33:865-872.
7. Paterson DL, Swindells S, Mohr J, Brewster M, Vergis EN et.al. Adherence to Protease Inhibitor and Outcomes in Patients with HIV Infection. Annals of Internal Medicine 2000;133(1): 21-30.
8. Day J, Godoka N, Nyamafeni P, Chigwanda M. Adherence to ART in clinical trial settings in Zimbabwe and Uganda: Lessons learned; Bangkok, Thailand.International Conference AIDS 2002 Jul;15: 11-16.
9. Bam K, Karki DK, Lohani SP, Thapa R, Aryal UR, Pathak LR. Adherence to antiretroviral therapy among people living with HIV and AIDS in far west, Nepal. Asian Journal of Medical Sciences 2011;2:7-13.
10. Lal V, Kant S, Dewan R, Rai SK, Biswas A. A two-site hospital-based study on factors associated with nonadherence to highly active antiretroviral therapy. Indian J public Health 2010;54(4):179-183.
11. Abaasa AM, Todd J, Ekoru K, Kalyango JN, Levin J, Odeke E et.al. Good adherence to HAART and improved survival in a community HIV/ AIDS treatment and care programme: the experience of The AIDS Support Organization (TASO), Kampala, Uganda. BMC Health Serv Res 2008;20;8:241.
12. Markos E, Worku A, Davey G. Adherence to ART in People Living with HIV/AIDS at Yirgalem Hospital, South Ethiopia. Ethiop.J.Health Dev 2008;22(2):174-179.
13. Joglekar N, Paranjape R, Jain R, Rahane G, Potdar R, Reddy KS et.al. Barriers to ART adherence & follow ups among patients attending ART centers in Maharashtra, India. India J Med Res 2011 134(6):954-9.
14. Sanjobo N, Frich JC, Fretheim A. Barriers and facilitators to patients' adherence to antiretroviral treatment in Zambia: a qualitative study. SAHARA J 2008 Sep;5(3):136-143.
15. Mothashari F, Riley E, Selwyn PA, Altice F. Acceptance and adherence with antiretroviral therapy among HIV-infected women in correctional facility. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology 1998;18: 341-348.
16. Morse EV, Simon PM, Coburn M, Hyslop N, Greenspan D, Balson PM. Determinants of subject compliance with an experimental anti-HIV drug protocol. Social Science and Medicine 1991;32: 1161-1167.
17. Pinheiro CA, De-Carvalho-Leite JC, Drachler ML, Silveira VL. Factors associated with adherence to antiretroviral therapy in HIV/AIDS patients: a cross-sectional study in Southern Brazil. Braz J Med Biol Res 2002; 35:1173-1181.